简体中文
EnglishWhat Healthcare Topics and Stories Are Featured on Roche's Website?
Updated
Roche's site organizes its public-facing content around three entry points: In the spotlight (current corporate and pipeline news), the Media center (press releases and company statements), and a stories section that explores healthcare questions in more depth. The topics range from company results and R&D targets to specific disease biology, diagnostic readiness, and the broader value of healthcare innovation.
Where the content lives
| Section | What it covers | Example from the site |
|---|---|---|
| In the spotlight | Timely corporate updates and patient-outcome highlights | Nine-month 2026 results (Group sales up 6% CER); a stated goal of up to 20 new medicines by 2030 |
| Media center | Press releases and official statements | Quarterly progress commentary from CEO Dr Thomas Schinecker |
| Stories | Longer-form explainers on science, disease, and health systems | Multiple sclerosis biology; sequencing by expansion (SBX); diagnostics and laboratory readiness |
| Investor information | Results, dividend, financial calendar | HY 2026 sales of CHF 30.4 billion; FY 2025 dividend yield of 3.2%; next report 28 January 2027 |
The themes behind the stories
Innovation value and health systems
One story series, "Unlocking what healthcare innovation is truly worth," argues that strong economies are built by healthy, productive populations. This is the site's framing piece for why investment in prevention and treatment matters beyond the clinic.
Disease biology: multiple sclerosis
A featured article explains why targeting both relapsing and progressive biology matters in MS, and how crossing the blood-brain barrier to address chronic inflammation may help prevent disability progression. This is the most disease-specific science content currently highlighted.
Diagnostics and health security
The site treats diagnostic and laboratory readiness as the starting point of health security, and profiles a sensitive new sequencing method called sequencing by expansion (SBX) as an example of diagnostic innovation.
The prevent–stop–cure framework
Roche frames its portfolio through three verbs, each tied to a type of solution:
- Prevent — identify high-risk patients early so medicines can be used in time.
- Stop — diagnose accurately and deliver targeted medicines to halt disease progression (diagnostics solutions).
- Cure — identify the cause of a condition and restore health through curative medicines (pharma solutions).
How to use the site
If you want company performance and dates, go to the Investor center. If you want official announcements, use the Media center. If you want to understand a scientific or system-level question, start with the stories section, which is where the MS, SBX, and innovation-value pieces sit. The "Read our story" and "View all stories" links are the main navigation points for that archive.
One caveat: the site presents these as highlights, not a complete catalogue of Roche's research. For pipeline detail or trial data, the stories page alone won't be sufficient.